"Family reunion" - A structured view on the composition of the receptor complexes of interleukin-6-type and interleukin-12-type cytokines

Cytokine and Growth Factor Reviews

Volumn 26, Issue 5, 2015, Pages 471-474

  Rose John, Stefan ^a   Scheller, Jürgen ^b   Schaper, Fred ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTROPHIN 1; CILIARY NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12P35; INTERLEUKIN 23P19; INTERLEUKIN 35; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR ALPHA; LEUKEMIA INHIBITORY FACTOR; PROTEIN P40; IL6 PROTEIN, HUMAN;

COMPLEX FORMATION; EDITORIAL; HEMATOLOGIC MALIGNANCY; HUMAN; INFLAMMATION; LIVER ADENOMA; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SOLID TUMOR; ANIMAL; CHEMISTRY; IMMUNOLOGY;

ANIMALS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-6; RECEPTORS, INTERLEUKIN-6;

EID: 84941941750     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2015.07.011     Document Type: Editorial

References (40)

1. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., et al. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 1988, 241:825-828.
2. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989, 58:573-581.
3. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990, 63:1149-1157.
4. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993, 260:1808-1810.
5. Ward L.D., Hammacher A., Howlett G.J., Matthews J.M., Fabri L., Moritz R.L., et al. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6 receptor complex. J. Biol. Chem. 1996, 271:20138-20144.
6. Mackiewicz A., Schooltink H., Heinrich P.C., Rose-John S. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J. Immunol. 1992, 149:2021-2027.
7. Jostock T., Müllberg J., Ozbek S., Atreya R., Blinn G., Voltz N., et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 2001, 268:160-167.
8. Müller-Newen G., Küster A., Hemmann U., Keul R., Horsten U., Martens A., et al. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J. Immunol. 1998, 161:6347-6355.
9. Narazaki M., Yasukawa K., Saito T., Ohsugi Y., Fukui H., Koishihara Y., et al. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 1993, 82:1120-1126.
10. Yasukawa K., Futatsugi K., Saito T., Yawata H., Narazaki M., Suzuki H., et al. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol. Lett. 1992, 31:123-130.
11. Yin T., Taga T., Tsang M.L., Yasukawa K., Kishimoto T., Yang Y.C. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J. Immunol. 1993, 151:2555-2561.
12. Hilton D.J., Hilton A.A., Raicevic A., Rakar S., Harrison-Smith M., Gough N.M., et al. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 1994, 13:4765-4775.
13. Nandurkar H.H., Hilton D.J., Nathan P., Willson T., Nicola N., Begley C.G. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. Oncogene 1996, 12:585-593.
14. Crabé S., Guay-Giroux A., Tormo A.J., Duluc D., Lissilaa R., Guilhot F., et al. The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J. Immunol. 2009, 183:7692-7702.
15. Garbers C., Spudy B., Aparicio-Siegmund S., Waetzig G.H., Sommer J., Holscher C., et al. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer. J. Biol. Chem. 2013, 288:4346-4354.
16. Davis S., Aldrich T.H., Stahl N., Pan L., Taga T., Kishimoto T., et al. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 1993, 260:1805-1808.
17. Senaldi G., Varnum B.C., Sarmiento U., Starnes C., Lile J., Scully S., et al. Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11458-11463.
18. Derouet D., Rousseau F., Alfonsi F., Froger J., Hermann J., Barbier F., et al. Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4827-4832.
19. Gearing D.P., Thut C.J., VandeBos T., Gimpel S.D., Delaney P.B., King J., et al. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 1991, 10:2839-2848.
20. Tormo A.J., Letellier M.C., Lissilaa R., Batraville L.A., Sharma M., Ferlin W., et al. The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities. Cytokine 2012, 60:653-660.
21. Gearing D.P., Comeau M.R., Friend D.J., Gimpel S.D., Thut C.J., McGourty J., et al. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992, 255:1434-1437.
22. Pennica D., King K.L., Shaw K.J., Luis E., Rullamas J., Luoh S.M., et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1142-1146.
23. Kuropatwinski K.K., De Imus C., Gearing D., Baumann H., Mosley B. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6. J. Biol. Chem. 1997, 272:15135-15144.
24. Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L.S., et al. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 1996, 271:32635-32643.
25. Ichihara M., Hara T., Kim H., Murate T., Miyajima A. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood 1997, 90:165-173.
26. Wang Y., Robledo O., Kinzie E., Blanchard F., Richards C., Miyajima A., et al. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J. Biol. Chem. 2000, 275:25273-25285.
27. Dillon S.R., Sprecher C., Hammond A., Bilsborough J., Rosenfeld-Franklin M., Presnell S.R., et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 2004, 5:752-760.
28. Diveu C., Lak-Hal A.H., Froger J., Ravon E., Grimaud L., Barbier F., et al. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur. Cytokine Netw. 2004, 15:291-302.
29. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 2002, 16:779-790.
30. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
31. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
32. Schoenhaut D.S., Chua A.O., Wolitzky A.G., Quinn P.M., Dwyer C.M., McComas W., et al. Cloning and expression of murine IL-12. J. Immunol. 1992, 148:3433-3440.
33. Wolf S.F., Temple P.A., Kobayashi M., Young D., Dicig M., Lowe L., et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 1991, 146:3074-3081.
34. Podlaski F.J., Nanduri V.B., Hulmes J.D., Pan Y.C., Levin W., Danho W., et al. Molecular characterization of interleukin 12. Arch. Biochem. Biophys. 1992, 294:230-237.
35. Schröder J., Moll J.M., Baran P., Grötzinger J., Scheller J., Floss D.M. Non-canonical interleukin 23 receptor complex assembly: p40 protein recruits interleukin 12 receptor beta1 via site II and induces p19/interleukin 23 receptor interaction via site III. J. Biol. Chem. 2015, 290:359-370.
36. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J.F., et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004, 172:2225-2231.
37. Collison L.W., Delgoffe G.M., Guy C.S., Vignali K.M., Chaturvedi V., Fairweather D., et al. The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 2012, 13:290-299.
38. Wang R.X., Yu C.R., Dambuza I.M., Mahdi R.M., Dolinska M.B., Sergeev Y.V., et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 2014, 20:633-641.
39. Presky D.H., Yang H., Minetti L.J., Chua A.O., Nabavi N., Wu C.Y., et al. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:14002-14007.
40. Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 2002, 168:5699-5708.